ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMM Immupharma Plc

2.18
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.18 2.10 2.26 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -1.93 7.33M
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 2.18p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares in issue. The market capitalisation of Immupharma is £7.33 million. Immupharma has a price to earnings ratio (PE ratio) of -1.93.

Immupharma Share Discussion Threads

Showing 32976 to 32996 of 39125 messages
Chat Pages: Latest  1325  1324  1323  1322  1321  1320  1319  1318  1317  1316  1315  1314  Older
DateSubjectAuthorDiscuss
29/7/2018
11:53
I have all the relevant experience and could tell them exactly what they should do! It is bleedin obvious to me.
nobbygnome
29/7/2018
11:39
Tracy Weimar would be a greater choice of consultant judging by her career. Stephane Mery has landed plenty of deals in his time too. Why the hell would they listen to a has been from the advfn message board.
a_2_b
29/7/2018
11:21
Do you think this will turn around ?
kirk 6
29/7/2018
11:14
I am not short. As I have oft repeated I am still interested in getting this drug to patients in the right way. The management here disgracefully are completely failing to do that. The answer is so simple, if they would just listen. I am happy to do some consultancy for them for a small fee...
nobbygnome
29/7/2018
11:08
Are you licensed to give financial advice? I would be civil to you if you were graceful to admit your short position here, otherwise there is very little reason for you to keep constantly posting the same negative information.
brad44
29/7/2018
08:42
Ken and nobby are so short that they tried smoking weed and couldn't get high
a_2_b
29/7/2018
07:14
Why are you so unpleasant? It is not my fault that you made the disaterous decision to buy IMM shares. Hanging on to them whilst the price dwindles away just isn't sensible IMHO......
nobbygnome
28/7/2018
22:44
A good trader would not still be holding here..... Even che has sold up and moved on!
nobbygnome
28/7/2018
21:52
45k edit 45p
kirk 6
28/7/2018
21:51
Down now about 180k more than some small fry can contemplate. Yes made about 70-80k on the bounce to 45k but I'm here to the end and deep pockets from massive profits but does hurt the way this keep falling. My holding now well over 1m
kirk 6
28/7/2018
18:00
Chart is looking a little sick now with further drop down predicted.
red army
28/7/2018
17:54
Those were not full results only top-line. Can take awhile for these deals to happen not something that can be done in mere weeks it's impossible.
a_2_b
28/7/2018
17:49
Yes, this is all speculation of course. Looking at the research section (www.gsk.com/en-gb/research/what-we-are-working-on/) seems a couple of products would conform to the pharmaceutical development programmes in place. IPP-102199 would fall under their consumer healthcare pain relief sector. Had nobby been a great scientist I'm sure there would of been a descent medicine by now. Fair play to them though must be a arduous task using a ladder to get to the keyboard all the time. At least we can back up what we say/think with credible information/links.
a_2_b
28/7/2018
17:28
>> Brad

Hmmm. The results were announced on April 17th. The date now is July 28th. By my calculations that is nearly 15 weeks. So allow them over 2 weeks to get the results out so say 12 weeks. So your calculation is a mere 100% out. Who is the stupid one 😂😂😂😂 8514;

nobbygnome
28/7/2018
15:25
On the GSK website there about us:"We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer."Benlysta must be a perfect example of this motto, not.
a_2_b
28/7/2018
14:15
All the board members bar Tim have had history with GSK that's pretty interesting. It seems they want to expand atm too as they haven't done much for awhile. Immunotherapy based treatments definitely seem like the future to me.
a_2_b
28/7/2018
11:03
Has to get past 18 first. Any good news in the meantime and your all toast.
a_2_b
28/7/2018
08:53
15p next week but managers will still enjoy their fine salaries until the cash runs out.
ken chung
27/7/2018
18:55
>>spawny

LOL. Sums up the rampers here! They have all departed stage left presumably because they have lost a fortune! Che was their cheerleader but we have heard nothing from him for weeks. I am sure his legions of followers would love to hear his rationale for selling out this wonderful company who are about to sign a deal on Lupuzor.........allegedly!

nobbygnome
27/7/2018
18:39
30p yet kirk?
spawny100
27/7/2018
16:19
So now in the 18s. Why would you hold on to these shares when you could get into companies with promise such as AOR, OPTI and SNG....
nobbygnome
Chat Pages: Latest  1325  1324  1323  1322  1321  1320  1319  1318  1317  1316  1315  1314  Older

Your Recent History

Delayed Upgrade Clock